Amyris

Amyris Financing Cash Flow

Delisted·May 7, 2024

The Net Financing Cash Flow of Amyris (AMRSQ) as of Nov 21, 2026 is 231.41 M USD. In the previous year, Net Financing Cash Flow was 701.96 M USD — a change of -67.03% (lower).

Financing Cash Flow

231.41 MUSD

YoY

-67.03%

Last updated:

Net Financing Cash Flow of Amyris is 2022 231.41 M USD. Net Financing Cash Flow of Amyris was 2021 701.96 M USD. It decreases by -67.03% lower compared to the previous year.

The Amyris Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2015
61.42 M USD
Jan 1, 2016
92.20 M USD
Jan 1, 2017
77.86 M USD
Jan 1, 2018
107.96 M USD
Jan 1, 2019
124.91 M USD
Jan 1, 2020
222.53 M USD
Jan 1, 2021
701.96 M USD
Jan 1, 2022
231.41 M USD
The Amyris Financing Cash Flow history
YEARFinancing Cash FlowYoY
231.41 MUSD-67.03%
701.96 MUSD+215.45%
222.53 MUSD+78.15%
124.91 MUSD+15.70%
107.96 MUSD+38.66%
77.86 MUSD-15.55%
92.20 MUSD+50.11%
61.42 MUSD-53.09%
130.92 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amyris Stock analysis

What does Amyris do? Amyris Inc. is a US-based company specializing in the production of sustainable products. It was founded in 2003 and is headquartered in Emeryville, California. The company aims to promote sustainability in daily life and reduce dependence on fossil fuels. Amyris' business model is based on the discovery and development of biological microorganisms capable of converting sugars and other carbohydrates into valuable products such as fuels, chemicals, and flavors. This technology, known as synthetic biology, was first used for the production of artemisinin, which is used against malaria. Over time, Amyris has expanded its portfolio and specialized in the production of sustainable products for the cosmetics, biofuel, food, and chemical industries. Leading products include Biosolve, an environmentally friendly degreasing solution for the industry, Neossance, a plant-based moisturizer for the cosmetics industry, and Biofene, a bio-based fuel. To produce its products, the company has formed partnerships with various organizations around the world. For example, it has partnered with Total, a French oil and gas company, to establish joint ventures for the production of biofuels. Amyris has also expanded its business by developing a platform for synthetic biology that allows other industry players to develop custom organisms for production processes. This new business model has brought the company into new markets such as the medical and energy sectors. In 2020, the COVID-19 pandemic posed challenges for the company as demand for some products declined. In response, Amyris shifted its production to disinfectants to meet the increased demand for these products. Overall, Amyris has become a leading company in sustainable production and is committed to promoting innovations in synthetic biology to have a positive impact on the environment. Amyris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amyris stock

Net Financing Cash Flow of Amyris is 231.41 M USD in 2022.

Net Financing Cash Flow of Amyris changed from 701.96 M USD to 231.41 M USD, representing a -67.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Amyris since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Amyris historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Amyris

All Key Metrics — Amyris